Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC2
|
ENSG00000169635.5 | HIC ZBTB transcriptional repressor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr22_21772274_21772425 | HIC2 | 656 | 0.570890 | 0.85 | 3.7e-03 | Click! |
chr22_21770706_21771053 | HIC2 | 814 | 0.475917 | 0.84 | 4.9e-03 | Click! |
chr22_21775153_21775531 | HIC2 | 417 | 0.747928 | 0.80 | 9.3e-03 | Click! |
chr22_21774905_21775056 | HIC2 | 55 | 0.956421 | 0.77 | 1.5e-02 | Click! |
chr22_21776760_21776911 | HIC2 | 1910 | 0.218105 | 0.70 | 3.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_944022_944173 | 1.05 |
ARID3A |
AT rich interactive domain 3A (BRIGHT-like) |
11588 |
0.08 |
chr6_167506513_167506813 | 1.00 |
CCR6 |
chemokine (C-C motif) receptor 6 |
18632 |
0.18 |
chr1_43396254_43396405 | 0.97 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
467 |
0.82 |
chr17_43488233_43488428 | 0.95 |
ARHGAP27 |
Rho GTPase activating protein 27 |
538 |
0.66 |
chr3_194456835_194457137 | 0.94 |
FAM43A |
family with sequence similarity 43, member A |
50364 |
0.11 |
chr1_156085465_156085736 | 0.91 |
LMNA |
lamin A/C |
1087 |
0.35 |
chr14_93500996_93501156 | 0.83 |
ITPK1 |
inositol-tetrakisphosphate 1-kinase |
31627 |
0.17 |
chr1_25886898_25887280 | 0.83 |
LDLRAP1 |
low density lipoprotein receptor adaptor protein 1 |
17018 |
0.19 |
chr3_48520196_48520441 | 0.81 |
SHISA5 |
shisa family member 5 |
5701 |
0.1 |
chr19_6775270_6775712 | 0.79 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
2522 |
0.19 |
chr22_47172138_47172381 | 0.77 |
TBC1D22A |
TBC1 domain family, member 22A |
2435 |
0.29 |
chr17_4091398_4091549 | 0.74 |
ANKFY1 |
ankyrin repeat and FYVE domain containing 1 |
1069 |
0.36 |
chr22_24824746_24825135 | 0.73 |
ADORA2A |
adenosine A2a receptor |
1410 |
0.42 |
chr1_43396548_43396786 | 0.73 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
129 |
0.96 |
chr11_46366527_46366708 | 0.70 |
DGKZ |
diacylglycerol kinase, zeta |
200 |
0.92 |
chr19_42702469_42702620 | 0.69 |
ENSG00000265122 |
. |
5314 |
0.1 |
chr22_43420415_43420626 | 0.69 |
PACSIN2 |
protein kinase C and casein kinase substrate in neurons 2 |
9369 |
0.18 |
chr3_49842166_49842317 | 0.68 |
ENSG00000263506 |
. |
1437 |
0.2 |
chr17_29817845_29818325 | 0.68 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
2959 |
0.19 |
chr17_38251746_38252035 | 0.67 |
NR1D1 |
nuclear receptor subfamily 1, group D, member 1 |
5088 |
0.13 |
chr17_76111954_76112105 | 0.67 |
ENSG00000204282 |
. |
4149 |
0.14 |
chr8_27223358_27224128 | 0.66 |
PTK2B |
protein tyrosine kinase 2 beta |
14425 |
0.22 |
chr3_49844438_49844854 | 0.66 |
ENSG00000263506 |
. |
968 |
0.33 |
chr9_132630795_132631295 | 0.66 |
USP20 |
ubiquitin specific peptidase 20 |
33288 |
0.12 |
chr16_28995183_28995334 | 0.65 |
LAT |
linker for activation of T cells |
889 |
0.35 |
chr17_42386672_42386888 | 0.65 |
RUNDC3A |
RUN domain containing 3A |
816 |
0.3 |
chr1_10804423_10804574 | 0.65 |
CASZ1 |
castor zinc finger 1 |
52207 |
0.13 |
chrX_19868073_19868317 | 0.64 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
37382 |
0.2 |
chr1_48174176_48174327 | 0.64 |
FLJ00388 |
|
53039 |
0.15 |
chr9_139686982_139687226 | 0.64 |
RP11-216L13.17 |
|
1273 |
0.17 |
chr6_3157097_3157483 | 0.64 |
TUBB2A |
tubulin, beta 2A class IIa |
470 |
0.75 |
chr6_154568216_154568453 | 0.63 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
31 |
0.99 |
chr19_36527909_36528122 | 0.63 |
CLIP3 |
CAP-GLY domain containing linker protein 3 |
3770 |
0.11 |
chr6_150525613_150525764 | 0.63 |
ENSG00000238594 |
. |
39968 |
0.16 |
chr16_30016741_30016892 | 0.62 |
DOC2A |
double C2-like domains, alpha |
1758 |
0.16 |
chr4_6698363_6699122 | 0.61 |
S100P |
S100 calcium binding protein P |
3946 |
0.17 |
chr9_139693729_139693891 | 0.61 |
CCDC183 |
coiled-coil domain containing 183 |
2995 |
0.09 |
chr22_20254654_20254883 | 0.61 |
RTN4R |
reticulon 4 receptor |
444 |
0.76 |
chr16_89514501_89514652 | 0.60 |
ENSG00000252887 |
. |
4850 |
0.14 |
chr16_81592162_81592485 | 0.60 |
CMIP |
c-Maf inducing protein |
63369 |
0.14 |
chr5_92920972_92921241 | 0.60 |
ENSG00000237187 |
. |
248 |
0.92 |
chr10_73517556_73517833 | 0.60 |
C10orf54 |
chromosome 10 open reading frame 54 |
307 |
0.9 |
chr19_41926852_41927085 | 0.60 |
BCKDHA |
branched chain keto acid dehydrogenase E1, alpha polypeptide |
2046 |
0.16 |
chr14_64932394_64932623 | 0.59 |
AKAP5 |
A kinase (PRKA) anchor protein 5 |
291 |
0.85 |
chr16_57176887_57177289 | 0.59 |
CPNE2 |
copine II |
23977 |
0.12 |
chr2_233923929_233924120 | 0.59 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
653 |
0.7 |
chr6_13253803_13254172 | 0.59 |
PHACTR1 |
phosphatase and actin regulator 1 |
18917 |
0.18 |
chr16_27474492_27474643 | 0.58 |
IL21R-AS1 |
IL21R antisense RNA 1 |
9853 |
0.19 |
chr17_37815369_37815608 | 0.58 |
TCAP |
titin-cap |
4952 |
0.12 |
chr1_10964678_10964936 | 0.58 |
C1orf127 |
chromosome 1 open reading frame 127 |
43120 |
0.13 |
chr10_134232211_134232487 | 0.58 |
PWWP2B |
PWWP domain containing 2B |
21647 |
0.15 |
chr19_2081862_2082033 | 0.58 |
MOB3A |
MOB kinase activator 3A |
3229 |
0.14 |
chr3_52257960_52258111 | 0.58 |
TLR9 |
toll-like receptor 9 |
2144 |
0.17 |
chr15_59646757_59646923 | 0.57 |
RP11-356M20.3 |
|
5248 |
0.14 |
chr9_92051867_92052150 | 0.57 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
610 |
0.8 |
chr1_167602468_167602965 | 0.57 |
RP3-455J7.4 |
|
2805 |
0.25 |
chr19_35703159_35703542 | 0.57 |
FAM187B |
family with sequence similarity 187, member B |
16282 |
0.09 |
chr17_43486150_43486442 | 0.57 |
ARHGAP27 |
Rho GTPase activating protein 27 |
1456 |
0.29 |
chr11_1777117_1777382 | 0.56 |
CTSD |
cathepsin D |
1073 |
0.3 |
chr14_91864420_91864751 | 0.56 |
CCDC88C |
coiled-coil domain containing 88C |
19105 |
0.21 |
chr10_134363469_134363620 | 0.56 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
11901 |
0.21 |
chr19_8641468_8641709 | 0.56 |
MYO1F |
myosin IF |
734 |
0.53 |
chr5_176788279_176788494 | 0.56 |
RGS14 |
regulator of G-protein signaling 14 |
3548 |
0.12 |
chr20_60606558_60606856 | 0.56 |
TAF4 |
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa |
24090 |
0.16 |
chr8_27217248_27217399 | 0.56 |
PTK2B |
protein tyrosine kinase 2 beta |
20845 |
0.2 |
chr17_30816321_30816550 | 0.56 |
CDK5R1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
1621 |
0.25 |
chr14_35809472_35809661 | 0.56 |
PSMA6 |
proteasome (prosome, macropain) subunit, alpha type, 6 |
29527 |
0.18 |
chr9_140347845_140347996 | 0.56 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
1024 |
0.39 |
chr9_95855910_95856313 | 0.55 |
RP11-274J16.5 |
|
1700 |
0.29 |
chr10_88123601_88123752 | 0.55 |
GRID1 |
glutamate receptor, ionotropic, delta 1 |
2559 |
0.34 |
chr17_17875229_17875380 | 0.55 |
TOM1L2 |
target of myb1-like 2 (chicken) |
407 |
0.67 |
chr22_30661215_30661706 | 0.55 |
OSM |
oncostatin M |
347 |
0.77 |
chr1_26158834_26159043 | 0.54 |
RP1-317E23.7 |
|
313 |
0.78 |
chr8_82008774_82009156 | 0.54 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
15338 |
0.28 |
chr1_10804701_10804852 | 0.54 |
CASZ1 |
castor zinc finger 1 |
51929 |
0.14 |
chr15_50540480_50540847 | 0.54 |
ENSG00000241175 |
. |
3535 |
0.19 |
chr22_37256493_37256696 | 0.54 |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
436 |
0.77 |
chr10_116303453_116303879 | 0.54 |
ABLIM1 |
actin binding LIM protein 1 |
16976 |
0.26 |
chr12_736828_736985 | 0.53 |
RP11-218M22.1 |
|
3151 |
0.2 |
chr12_10283112_10283263 | 0.53 |
CLEC7A |
C-type lectin domain family 7, member A |
331 |
0.83 |
chr1_2347463_2347709 | 0.53 |
PEX10 |
peroxisomal biogenesis factor 10 |
2350 |
0.17 |
chr9_95893318_95893469 | 0.53 |
NINJ1 |
ninjurin 1 |
3177 |
0.23 |
chr1_154981820_154981971 | 0.53 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5029 |
0.08 |
chr5_92916038_92916263 | 0.53 |
ENSG00000237187 |
. |
563 |
0.76 |
chr1_27695839_27696024 | 0.53 |
MAP3K6 |
mitogen-activated protein kinase kinase kinase 6 |
2548 |
0.17 |
chr1_25322247_25322533 | 0.53 |
ENSG00000264371 |
. |
27604 |
0.16 |
chr11_65171312_65171860 | 0.53 |
FRMD8 |
FERM domain containing 8 |
17187 |
0.1 |
chr13_49153726_49154142 | 0.52 |
RCBTB2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
46565 |
0.18 |
chr1_200995665_200996045 | 0.52 |
KIF21B |
kinesin family member 21B |
3027 |
0.24 |
chr6_42015063_42015705 | 0.52 |
CCND3 |
cyclin D3 |
1040 |
0.46 |
chr9_129263029_129263255 | 0.52 |
ENSG00000221768 |
. |
30128 |
0.17 |
chr15_75326864_75327088 | 0.52 |
PPCDC |
phosphopantothenoylcysteine decarboxylase |
6386 |
0.16 |
chr7_150683311_150683462 | 0.52 |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
4697 |
0.13 |
chr6_35436712_35436863 | 0.52 |
RPL10A |
ribosomal protein L10a |
602 |
0.7 |
chr11_46360658_46360927 | 0.52 |
DGKZ |
diacylglycerol kinase, zeta |
644 |
0.66 |
chr19_18198622_18198789 | 0.52 |
IL12RB1 |
interleukin 12 receptor, beta 1 |
892 |
0.5 |
chr19_42702815_42703281 | 0.52 |
ENSG00000265122 |
. |
5818 |
0.1 |
chr19_1248601_1248752 | 0.51 |
MIDN |
midnolin |
124 |
0.91 |
chr3_5061626_5061929 | 0.51 |
BHLHE40-AS1 |
BHLHE40 antisense RNA 1 |
40131 |
0.14 |
chr20_58629871_58630470 | 0.51 |
C20orf197 |
chromosome 20 open reading frame 197 |
810 |
0.71 |
chr1_28202718_28203046 | 0.51 |
THEMIS2 |
thymocyte selection associated family member 2 |
3360 |
0.15 |
chr14_35516091_35516257 | 0.51 |
FAM177A1 |
family with sequence similarity 177, member A1 |
565 |
0.77 |
chrX_128908304_128908465 | 0.51 |
SASH3 |
SAM and SH3 domain containing 3 |
5576 |
0.21 |
chr17_74099033_74099300 | 0.51 |
EXOC7 |
exocyst complex component 7 |
141 |
0.93 |
chr8_142182069_142182309 | 0.51 |
DENND3 |
DENN/MADD domain containing 3 |
6031 |
0.21 |
chr15_89198697_89199209 | 0.51 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
16769 |
0.16 |
chr5_40515350_40515665 | 0.51 |
ENSG00000199552 |
. |
139558 |
0.05 |
chr2_136742943_136743094 | 0.50 |
AC093391.2 |
|
26 |
0.51 |
chr6_13428221_13428403 | 0.50 |
GFOD1 |
glucose-fructose oxidoreductase domain containing 1 |
19943 |
0.18 |
chr14_24783116_24783339 | 0.50 |
LTB4R |
leukotriene B4 receptor |
107 |
0.89 |
chr14_95961574_95961848 | 0.50 |
SYNE3 |
spectrin repeat containing, nuclear envelope family member 3 |
19538 |
0.14 |
chr11_64126806_64126957 | 0.50 |
RPS6KA4 |
ribosomal protein S6 kinase, 90kDa, polypeptide 4 |
125 |
0.92 |
chr20_24665676_24665827 | 0.50 |
SYNDIG1 |
synapse differentiation inducing 1 |
215916 |
0.02 |
chr1_203597474_203597694 | 0.50 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
1656 |
0.46 |
chr19_49971936_49972087 | 0.50 |
FLT3LG |
fms-related tyrosine kinase 3 ligand |
5474 |
0.06 |
chr19_51645005_51645224 | 0.50 |
SIGLEC7 |
sialic acid binding Ig-like lectin 7 |
442 |
0.65 |
chr17_72920002_72920279 | 0.50 |
OTOP2 |
otopetrin 2 |
230 |
0.78 |
chr16_3070538_3070989 | 0.50 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
383 |
0.5 |
chr2_74175450_74175659 | 0.50 |
ENSG00000201876 |
. |
19779 |
0.14 |
chr2_220223191_220223389 | 0.50 |
RESP18 |
regulated endocrine-specific protein 18 |
25391 |
0.08 |
chr13_33591506_33591771 | 0.49 |
KL |
klotho |
1067 |
0.6 |
chr1_40531296_40531504 | 0.49 |
PPT1 |
palmitoyl-protein thioesterase 1 |
16593 |
0.17 |
chr3_10707981_10708310 | 0.49 |
ATP2B2-IT2 |
ATP2B2 intronic transcript 2 (non-protein coding) |
39653 |
0.15 |
chr12_7069437_7069760 | 0.49 |
ENSG00000207713 |
. |
3264 |
0.07 |
chr1_160684089_160684457 | 0.49 |
CD48 |
CD48 molecule |
2632 |
0.23 |
chr17_76125845_76126093 | 0.49 |
TMC6 |
transmembrane channel-like 6 |
795 |
0.36 |
chr12_50362919_50363070 | 0.49 |
AQP6 |
aquaporin 6, kidney specific |
1972 |
0.19 |
chr5_131821826_131822053 | 0.49 |
IRF1 |
interferon regulatory factor 1 |
3398 |
0.17 |
chr11_57136182_57136499 | 0.49 |
ENSG00000266018 |
. |
9144 |
0.09 |
chr3_46264039_46264203 | 0.49 |
CCR1 |
chemokine (C-C motif) receptor 1 |
14234 |
0.2 |
chr2_73181844_73181995 | 0.48 |
EMX1 |
empty spiracles homeobox 1 |
30802 |
0.19 |
chr4_154581972_154582143 | 0.48 |
RP11-153M7.3 |
|
17354 |
0.19 |
chrX_70504678_70505140 | 0.48 |
NONO |
non-POU domain containing, octamer-binding |
865 |
0.55 |
chr22_38072303_38072524 | 0.48 |
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
798 |
0.43 |
chr20_62685029_62685328 | 0.48 |
RP13-152O15.5 |
|
2978 |
0.12 |
chr17_2696074_2696428 | 0.48 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
3481 |
0.22 |
chr16_84771404_84771581 | 0.48 |
USP10 |
ubiquitin specific peptidase 10 |
30379 |
0.17 |
chr15_62123968_62124119 | 0.48 |
RP11-16B9.1 |
|
2908 |
0.36 |
chr2_231523986_231524574 | 0.47 |
CAB39 |
calcium binding protein 39 |
53280 |
0.12 |
chr4_1762437_1762588 | 0.47 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
32381 |
0.11 |
chr11_85338949_85339118 | 0.47 |
TMEM126B |
transmembrane protein 126B |
596 |
0.48 |
chr6_41166873_41167272 | 0.47 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
1860 |
0.24 |
chr1_175156305_175156626 | 0.47 |
KIAA0040 |
KIAA0040 |
5425 |
0.29 |
chr5_176859524_176860060 | 0.47 |
GRK6 |
G protein-coupled receptor kinase 6 |
5937 |
0.1 |
chr14_55596656_55596883 | 0.47 |
LGALS3 |
lectin, galactoside-binding, soluble, 3 |
791 |
0.69 |
chr10_73849703_73850335 | 0.47 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
1229 |
0.53 |
chr22_30699623_30699911 | 0.47 |
TBC1D10A |
TBC1 domain family, member 10A |
1853 |
0.19 |
chr3_151987950_151988161 | 0.47 |
MBNL1-AS1 |
MBNL1 antisense RNA 1 |
711 |
0.49 |
chr14_91711549_91711700 | 0.47 |
GPR68 |
G protein-coupled receptor 68 |
772 |
0.58 |
chr19_14694241_14694427 | 0.47 |
CLEC17A |
C-type lectin domain family 17, member A |
399 |
0.54 |
chr11_72915537_72915717 | 0.47 |
RP11-800A3.2 |
|
11331 |
0.15 |
chr1_26869137_26869550 | 0.47 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
260 |
0.89 |
chr6_37171378_37171645 | 0.47 |
ENSG00000252687 |
. |
20067 |
0.15 |
chr3_50647617_50647972 | 0.47 |
CISH |
cytokine inducible SH2-containing protein |
1409 |
0.29 |
chr9_131485810_131486083 | 0.47 |
ZDHHC12 |
zinc finger, DHHC-type containing 12 |
439 |
0.56 |
chr2_55276476_55276645 | 0.47 |
RTN4 |
reticulon 4 |
216 |
0.95 |
chr21_46910341_46910492 | 0.47 |
COL18A1 |
collagen, type XVIII, alpha 1 |
227 |
0.94 |
chr17_29837359_29837510 | 0.47 |
ENSG00000264862 |
. |
8016 |
0.13 |
chr14_35838842_35838993 | 0.47 |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
34429 |
0.18 |
chr4_2788254_2788526 | 0.46 |
SH3BP2 |
SH3-domain binding protein 2 |
6360 |
0.21 |
chr14_91303239_91303521 | 0.46 |
TTC7B |
tetratricopeptide repeat domain 7B |
20557 |
0.25 |
chr16_21530450_21530688 | 0.46 |
ENSG00000265462 |
. |
13113 |
0.15 |
chr1_228343234_228343385 | 0.46 |
GJC2 |
gap junction protein, gamma 2, 47kDa |
5756 |
0.11 |
chr16_57678201_57678352 | 0.46 |
GPR56 |
G protein-coupled receptor 56 |
1357 |
0.34 |
chr9_137291629_137291836 | 0.46 |
RXRA |
retinoid X receptor, alpha |
6696 |
0.25 |
chr1_2431041_2431419 | 0.46 |
RP3-395M20.3 |
|
5312 |
0.11 |
chr17_7457298_7457516 | 0.46 |
TNFSF13 |
tumor necrosis factor (ligand) superfamily, member 13 |
4202 |
0.06 |
chr21_43688084_43688300 | 0.46 |
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
11733 |
0.16 |
chr9_134531466_134531882 | 0.46 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
30339 |
0.18 |
chrX_129243058_129243209 | 0.46 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
1203 |
0.51 |
chr14_65788655_65788806 | 0.46 |
ENSG00000266740 |
. |
13171 |
0.26 |
chr3_56934168_56934395 | 0.46 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
16218 |
0.23 |
chr17_62778302_62778575 | 0.46 |
RP13-104F24.1 |
|
23717 |
0.13 |
chr19_13086028_13086179 | 0.46 |
DAND5 |
DAN domain family member 5, BMP antagonist |
5807 |
0.08 |
chr1_26616574_26616764 | 0.46 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
10056 |
0.11 |
chr2_73519533_73519798 | 0.45 |
EGR4 |
early growth response 4 |
1164 |
0.4 |
chr10_45443543_45443826 | 0.45 |
RP11-285G1.14 |
|
11222 |
0.12 |
chr4_154712833_154713000 | 0.45 |
SFRP2 |
secreted frizzled-related protein 2 |
2644 |
0.3 |
chr22_20783906_20784182 | 0.45 |
SCARF2 |
scavenger receptor class F, member 2 |
8068 |
0.11 |
chr15_75065843_75066180 | 0.45 |
CSK |
c-src tyrosine kinase |
8387 |
0.12 |
chr11_64019459_64019703 | 0.45 |
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
534 |
0.47 |
chr1_155055289_155055481 | 0.45 |
EFNA3 |
ephrin-A3 |
4000 |
0.09 |
chr5_169716215_169716465 | 0.45 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
8891 |
0.23 |
chr8_12989596_12990152 | 0.45 |
DLC1 |
deleted in liver cancer 1 |
1109 |
0.58 |
chr10_134234500_134234673 | 0.44 |
RP11-432J24.3 |
|
20402 |
0.15 |
chr8_144658791_144658942 | 0.44 |
NAPRT1 |
nicotinate phosphoribosyltransferase domain containing 1 |
1642 |
0.14 |
chr14_65189299_65189738 | 0.44 |
PLEKHG3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
981 |
0.61 |
chr9_140357412_140357637 | 0.44 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
3738 |
0.15 |
chr6_56819036_56819440 | 0.44 |
DST |
dystonin |
147 |
0.84 |
chr5_176799321_176799505 | 0.44 |
RGS14 |
regulator of G-protein signaling 14 |
5469 |
0.1 |
chr11_113954124_113954326 | 0.44 |
ENSG00000221112 |
. |
3426 |
0.27 |
chr3_5223214_5223592 | 0.44 |
AC026202.3 |
|
5611 |
0.17 |
chr11_1893858_1894093 | 0.44 |
LSP1 |
lymphocyte-specific protein 1 |
1859 |
0.19 |
chr11_62476081_62476232 | 0.44 |
BSCL2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
380 |
0.57 |
chr8_142181881_142182032 | 0.44 |
DENND3 |
DENN/MADD domain containing 3 |
6264 |
0.21 |
chr1_32816194_32816561 | 0.44 |
TSSK3 |
testis-specific serine kinase 3 |
2678 |
0.17 |
chr17_72460849_72461119 | 0.43 |
CD300A |
CD300a molecule |
1571 |
0.32 |
chr21_47059833_47059985 | 0.43 |
PCBP3 |
poly(rC) binding protein 3 |
3699 |
0.31 |
chr12_96443277_96443505 | 0.43 |
LTA4H |
leukotriene A4 hydrolase |
6093 |
0.17 |
chr12_4398894_4399263 | 0.43 |
CCND2-AS1 |
CCND2 antisense RNA 1 |
13728 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 1.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 1.9 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.5 | 1.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.1 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.3 | 1.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 2.7 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.3 | GO:0030004 | cellular monovalent inorganic cation homeostasis(GO:0030004) |
0.3 | 1.6 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 0.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 1.5 | GO:0001820 | serotonin secretion(GO:0001820) |
0.3 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 2.0 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.3 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 0.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 1.1 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.3 | 0.8 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.3 | 0.3 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 1.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.3 | 0.5 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.3 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.7 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 0.7 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 1.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 0.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 2.6 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 0.2 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.2 | 0.6 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.2 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.2 | 0.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.8 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.2 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 4.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 2.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.2 | 0.8 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.2 | 0.8 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.2 | 0.6 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.7 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.6 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.4 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 1.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.2 | 0.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.2 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.2 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 2.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.2 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.2 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.5 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.2 | 0.2 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.2 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) modulation of growth of symbiont involved in interaction with host(GO:0044144) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 0.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.5 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.2 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.2 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.2 | 0.2 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.2 | 0.5 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.2 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.2 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.2 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.6 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.2 | 1.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.9 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.5 | GO:0061054 | dermatome development(GO:0061054) |
0.2 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 2.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.8 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.2 | 0.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 0.6 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.2 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.1 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.1 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.6 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.7 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.6 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.4 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.1 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 1.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 1.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0060759 | regulation of response to cytokine stimulus(GO:0060759) |
0.1 | 0.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 2.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 1.0 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.3 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.2 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 1.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.7 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.1 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.1 | 0.5 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 1.3 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.4 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 1.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.4 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 1.3 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0072338 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.6 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.2 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.1 | 0.3 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) |
0.1 | 0.2 | GO:0033088 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.3 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.1 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 0.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.3 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.5 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.9 | GO:0071333 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.1 | 0.2 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.7 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.3 | GO:2000192 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.1 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 1.6 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.1 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.1 | GO:0002524 | hypersensitivity(GO:0002524) regulation of acute inflammatory response to antigenic stimulus(GO:0002864) positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) regulation of hypersensitivity(GO:0002883) positive regulation of hypersensitivity(GO:0002885) |
0.1 | 0.7 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 0.7 | GO:0018195 | peptidyl-arginine modification(GO:0018195) peptidyl-arginine methylation(GO:0018216) |
0.1 | 1.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 2.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.3 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.4 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.2 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.4 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.6 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 1.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.2 | GO:0001839 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.1 | 0.1 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.2 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.6 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.1 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0098900 | regulation of action potential(GO:0098900) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.5 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.1 | 0.7 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.2 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 1.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.9 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0042516 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.3 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.1 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.2 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.7 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0070977 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 3.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.7 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 4.1 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 0.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.3 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.1 | GO:0061316 | canonical Wnt signaling pathway involved in heart development(GO:0061316) |
0.1 | 0.1 | GO:0006900 | membrane budding(GO:0006900) |
0.1 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.2 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 1.0 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 1.4 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 1.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.4 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.9 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.5 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.1 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.4 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.1 | 1.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.1 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.1 | 1.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.3 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.1 | 0.6 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.3 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.5 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.3 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 0.9 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 2.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.3 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 1.4 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.2 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.3 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.1 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.6 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.2 | GO:0006560 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.3 | GO:1903039 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.4 | GO:1905144 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0042551 | neuron maturation(GO:0042551) |
0.1 | 0.7 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.1 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 0.1 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.7 | GO:0009988 | binding of sperm to zona pellucida(GO:0007339) cell-cell recognition(GO:0009988) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.5 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.1 | GO:0097154 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.1 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.4 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.1 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.3 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 2.0 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.7 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.3 | GO:0051783 | regulation of nuclear division(GO:0051783) |
0.0 | 0.5 | GO:0030217 | T cell differentiation(GO:0030217) |
0.0 | 2.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.2 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.5 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.0 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.4 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0043650 | quinolinate biosynthetic process(GO:0019805) dicarboxylic acid biosynthetic process(GO:0043650) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.0 | GO:0060401 | cytosolic calcium ion transport(GO:0060401) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar cortex formation(GO:0021697) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.6 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.4 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 1.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.3 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.0 | 0.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.4 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 1.8 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.0 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.7 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.2 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.0 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.0 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 1.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.2 | GO:0034109 | homotypic cell-cell adhesion(GO:0034109) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 3.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.0 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.0 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.4 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.2 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 1.8 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.4 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.0 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.1 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.0 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 1.9 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.0 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.2 | GO:0002221 | pattern recognition receptor signaling pathway(GO:0002221) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 1.6 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.1 | GO:1903792 | negative regulation of anion transport(GO:1903792) |
0.0 | 0.1 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.0 | 0.0 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.4 | GO:0015838 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.0 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.2 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.2 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 1.1 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.2 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 0.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.3 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 0.5 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.2 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.6 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.0 | 2.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.9 | GO:0007034 | vacuolar transport(GO:0007034) |
0.0 | 0.3 | GO:0010921 | regulation of phosphatase activity(GO:0010921) regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.3 | GO:0051322 | anaphase(GO:0051322) |
0.0 | 1.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.2 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.7 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.2 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 1.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 3.0 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:1903409 | reactive oxygen species biosynthetic process(GO:1903409) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 2.3 | GO:0070085 | glycosylation(GO:0070085) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.0 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 5.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.2 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 1.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 1.4 | GO:0006887 | exocytosis(GO:0006887) |
0.0 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.0 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.5 | GO:0046461 | triglyceride catabolic process(GO:0019433) neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 1.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0042310 | vasoconstriction(GO:0042310) |
0.0 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 3.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.6 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.0 | 1.2 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 1.1 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 1.8 | GO:0050900 | leukocyte migration(GO:0050900) |
0.0 | 0.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.1 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.0 | 0.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 1.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.6 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 3.7 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 1.0 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.0 | 0.1 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0032609 | interferon-gamma production(GO:0032609) regulation of interferon-gamma production(GO:0032649) |
0.0 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 1.0 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.2 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.0 | GO:1900543 | negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of purine nucleotide metabolic process(GO:1900543) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 2.2 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.2 | GO:0015918 | sterol transport(GO:0015918) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.1 | GO:0001708 | cell fate specification(GO:0001708) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 3.6 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.6 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.2 | GO:0021675 | nerve development(GO:0021675) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.5 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.1 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.0 | 0.0 | GO:0021561 | facial nerve development(GO:0021561) |
0.0 | 0.1 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0015800 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.0 | 0.4 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 0.0 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 1.0 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.2 | GO:0042063 | gliogenesis(GO:0042063) |
0.0 | 0.0 | GO:0043112 | receptor metabolic process(GO:0043112) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 1.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0035967 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.2 | GO:0071593 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.0 | 0.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:0045217 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 4.2 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.4 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 1.0 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.2 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:2000278 | regulation of telomerase activity(GO:0051972) regulation of DNA biosynthetic process(GO:2000278) |
0.0 | 0.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 1.4 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.0 | GO:0061387 | regulation of axon extension(GO:0030516) regulation of extent of cell growth(GO:0061387) |
0.0 | 0.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 2.5 | GO:0006952 | defense response(GO:0006952) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.6 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.0 | 0.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.0 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0048387 | regulation of retinoic acid receptor signaling pathway(GO:0048385) negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.3 | GO:1903046 | meiotic cell cycle process(GO:1903046) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.4 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 1.6 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.0 | 0.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 1.0 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 3.6 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0048588 | developmental cell growth(GO:0048588) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 2.2 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.1 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.8 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0031929 | TOR signaling(GO:0031929) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 1.0 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.3 | 1.9 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 1.0 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 2.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.1 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 2.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.1 | GO:0043656 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 2.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 4.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 3.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.1 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 1.4 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.5 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 4.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.0 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 3.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.5 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 1.9 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 0.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.7 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.1 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 1.7 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 4.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.4 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 3.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 6.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 6.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 2.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 5.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 4.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.5 | GO:0005768 | endosome(GO:0005768) |
0.0 | 2.8 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 4.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 4.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.7 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.0 | 1.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 2.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 2.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.6 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 1.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 3.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 1.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 1.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 6.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 1.1 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 1.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 2.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0008278 | cohesin complex(GO:0008278) meiotic cohesin complex(GO:0030893) |
0.0 | 0.0 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.0 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 1.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 2.1 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 1.3 | GO:0031410 | cytoplasmic vesicle(GO:0031410) intracellular vesicle(GO:0097708) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.2 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 1.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 39.1 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 8.5 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 1.6 | GO:0005819 | spindle(GO:0005819) |
0.0 | 4.6 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.0 | 0.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 8.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.0 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 3.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.2 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 13.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.3 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0030496 | midbody(GO:0030496) |
0.0 | 76.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.3 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.0 | GO:0044454 | nuclear chromosome part(GO:0044454) |
0.0 | 6.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.9 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 44.0 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 1.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 0.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.4 | 2.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 1.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 3.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.2 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.6 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 2.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.5 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.7 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 1.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.6 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.7 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 6.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.8 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.5 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 2.0 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.0 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.2 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.2 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 2.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.7 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 1.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 1.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 2.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 1.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.7 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.3 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 0.5 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 1.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 2.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.1 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.8 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 3.1 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.3 | GO:0016803 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 1.1 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.8 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.7 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.1 | 0.2 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 1.9 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.1 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.6 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.9 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 1.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 2.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 1.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.5 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 5.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 1.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 1.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.4 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 2.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.5 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.8 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.9 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.5 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 2.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 1.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 4.4 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.3 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.0 | GO:0052742 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol kinase activity(GO:0052742) |
0.0 | 2.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.9 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 8.0 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.8 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.5 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 16.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 3.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 1.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 4.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 6.0 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.1 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.4 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 5.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 35.9 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.6 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 3.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.4 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 2.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.5 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 1.0 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 3.6 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.4 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 1.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.1 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.4 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.8 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.0 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 13.6 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 2.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.0 | GO:0046527 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) glucosyltransferase activity(GO:0046527) |
0.0 | 0.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.3 | GO:0004518 | nuclease activity(GO:0004518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 1.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 5.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 3.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 6.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 3.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 2.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 8.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 4.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 3.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 3.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 5.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 1.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 2.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 5.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 2.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 1.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.1 | 1.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 1.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 4.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 3.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 5.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.1 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.1 | 1.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 3.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 2.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 3.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 2.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 3.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.4 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 2.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 4.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 3.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 3.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 3.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.5 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 3.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 1.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 3.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 1.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 5.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |